Reza Shojaei Asks: What if Your Country Could Stop Depending on Imported Plasma Medicines, Permanently?
Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources, shared on LinkedIn:
“What if your country could stop depending on imported plasma medicines, permanently?
For decades, most nations accepted plasma dependency as inevitable. Today, one country has proven that assumption wrong.
Egypt is now one of only a few countries in the world to achieve full national self-sufficiency in essential plasma-derived medicines, including IVIG, albumin, and hemophilia clotting factors. And it didn’t take 50 years to execute once the strategy was right; it took just five.
This transformation was not accidental. It was built through:
- Presidential-level political commitment
- A first-of-its-kind public–private joint venture
- FDA-aligned regulation
- Compensated, medically monitored donors
- And full vein-to-vial industrial integration
In this edition of Blood and Plasma Pulse, we unpack Egypt’s 50-year journey from early failed fractionation attempts to becoming Africa’s first plasma manufacturing hub, and what policymakers, regulators, and health system leaders around the world can learn from it, right now.
If your country is facing:
- IVIG shortages
- Rising plasma medicine costs
- Import dependency
- Or national biologics insecurity
This is not a story you can afford to ignore.”
Read full paper here.
Read more from Reza Shojaei on Hemostasis Today.
-
Sep 23, 2026, 02:35Udaya RajBhandari: A Hidden Risk of Repeated Transfusions in β Thalassemia
-
Sep 23, 2026, 00:08Janar Sathananthan: The Importance of Durable Drug Delivery in DCB Therapy
-
Sep 23, 2026, 00:07Arun V J: How Does a Good Conference Destroy My Ego?
-
Sep 23, 2026, 00:06Akshat Jain: Sickle Cell Disease Is Not One Size Fits All
-
Sep 23, 2026, 00:05Sherri Ozawa: Nicole De Vita’s Iron Deficiency Infographic Recognized at SABM
-
Sep 23, 2026, 00:04Zafar Ali: How Does Hemoglobin Know When to Hold Oxygen and When to Let It Go?
-
Sep 23, 2026, 00:02Ahmed Elsharkawy: Drug-Drug and Drug-Diluent Incompatibilities in ICUs and Hematology Units
-
Sep 22, 2026, 23:58Nishant Rajendra Tiwari: Hereditary TTP With the Same ADAMTS13 Variants but Strikingly Different Disease Courses
-
Sep 22, 2026, 23:57Akhil Santhosh: Pacritinib Versus Ruxolitinib in Myelofibrosis With Thrombocytopenia